NO20065485L - Kjemiske forbindelser - Google Patents

Kjemiske forbindelser

Info

Publication number
NO20065485L
NO20065485L NO20065485A NO20065485A NO20065485L NO 20065485 L NO20065485 L NO 20065485L NO 20065485 A NO20065485 A NO 20065485A NO 20065485 A NO20065485 A NO 20065485A NO 20065485 L NO20065485 L NO 20065485L
Authority
NO
Norway
Prior art keywords
chemical connections
smilagenin
connections
chemical
hydrated
Prior art date
Application number
NO20065485A
Other languages
English (en)
Norwegian (no)
Inventor
Peter David Tiffin
Original Assignee
Phytopharm Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phytopharm Plc filed Critical Phytopharm Plc
Publication of NO20065485L publication Critical patent/NO20065485L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO20065485A 2004-04-28 2006-11-28 Kjemiske forbindelser NO20065485L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0409567.5A GB0409567D0 (en) 2004-04-28 2004-04-28 Chemical compounds
PCT/GB2005/001635 WO2005105825A2 (en) 2004-04-28 2005-04-28 Crystalline and amorphous forms of smilagenin

Publications (1)

Publication Number Publication Date
NO20065485L true NO20065485L (no) 2007-01-29

Family

ID=32408243

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065485A NO20065485L (no) 2004-04-28 2006-11-28 Kjemiske forbindelser

Country Status (17)

Country Link
US (2) US20080004249A1 (ja)
EP (2) EP1742960A2 (ja)
JP (1) JP2007534736A (ja)
KR (1) KR20070028387A (ja)
CN (2) CN102516352A (ja)
AU (1) AU2005238274A1 (ja)
BR (1) BRPI0510458A (ja)
CA (1) CA2564368A1 (ja)
GB (1) GB0409567D0 (ja)
IL (1) IL178870A0 (ja)
MX (1) MXPA06012641A (ja)
NO (1) NO20065485L (ja)
RU (1) RU2006141389A (ja)
SG (1) SG155165A1 (ja)
TW (1) TW200538145A (ja)
WO (1) WO2005105825A2 (ja)
ZA (1) ZA200609596B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110115589A (ko) 2009-01-24 2011-10-21 파이토팜 피엘씨 신경영양인자가 매개된 장애의 치료
KR20130043197A (ko) 2010-07-20 2013-04-29 파이토팜 피엘씨 엘-도파, 도파민 효능제 및/또는 도파민 증강제 유도된 장애의 치료

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE632276A (ja) * 1962-05-15
US3169959A (en) * 1963-07-23 1965-02-16 Intermediates Inc Method of obtaining smilagenin
CA985172A (en) 1972-10-06 1976-03-09 Dushan M. Dvornik Compositions and methods for reducing blood cholesterol
US4602003A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia
US4680289A (en) * 1985-06-05 1987-07-14 Progenics, Inc. Treatment of obesity and diabetes using sapogenins
US5017562A (en) 1987-02-11 1991-05-21 Regents Of The University Of Minnesota Crystalline saponin-containing complex
GB9923076D0 (en) 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
EP1719512B1 (en) * 1998-03-26 2011-05-04 Phytopharm Plc Sarsasapogenin and smilagenin for treating cognitive dysfunctions
GB9905275D0 (en) 1999-03-08 1999-04-28 Phytopharm Ltd Treatment of conditions associated with membrane-bound receptors and their function
GB9923078D0 (en) 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
AT409100B (de) 2000-07-24 2002-05-27 Evg Entwicklung Verwert Ges Vorrichtung zum schweissen einer drahtgittermatte
GB0107822D0 (en) 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
WO2003082893A2 (en) 2002-03-27 2003-10-09 Phytopharm Plc Theraputic methods and uses of sapogenins and their derivatives
BR0315746A (pt) * 2002-10-28 2005-09-06 Phytopharm Plc Redução estereospecìfica de sapogen-3-onas

Also Published As

Publication number Publication date
KR20070028387A (ko) 2007-03-12
RU2006141389A (ru) 2008-06-10
MXPA06012641A (es) 2006-12-15
EP2402362A2 (en) 2012-01-04
ZA200609596B (en) 2008-01-30
WO2005105825A3 (en) 2006-02-23
AU2005238274A1 (en) 2005-11-10
US20080004249A1 (en) 2008-01-03
EP1742960A2 (en) 2007-01-17
CN102516352A (zh) 2012-06-27
CN101076539A (zh) 2007-11-21
CA2564368A1 (en) 2005-11-10
JP2007534736A (ja) 2007-11-29
WO2005105825A2 (en) 2005-11-10
US20110144323A1 (en) 2011-06-16
IL178870A0 (en) 2007-03-08
TW200538145A (en) 2005-12-01
SG155165A1 (en) 2009-09-30
GB0409567D0 (en) 2004-06-02
BRPI0510458A (pt) 2007-10-30

Similar Documents

Publication Publication Date Title
NO20055686L (no) Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav.
WO2005105785A3 (en) Indole derivatives for treatment of obesity
NO20071549L (no) Nye benzofuserte heteroalrylsulfamidderivater, anvendelige som anti-krampemidler
ZA201201391B (en) Methods, compositions, and kits for the treatment of medical conditions
NO20055204D0 (no) Derivater av piperidinyl- og pipemzinylalkylkarbamater, fremgangsmater for fremstilling derav og anvendelse av de samme i terapi
IS7881A (is) CHK-, PDK- og AKT-hindrandi pýrimidín, framleiðsla þeirra og notkun sem lyfjaefni
DK1928840T3 (da) 1H-pyrazol-4-carboxamider, deres fremstilling og deres anvendelse som 11-beta-hydroxysteroid-dehydrogenaseinhibitorer
NO20051503D0 (no) Pyrazolopyridiner og fremgangsmater for fremstilling og anvendelse av de samme.
ZA200804079B (en) Parthenogenic activation of human oocytes for the production of human embroyonic stem cells
DK1670458T3 (da) 1-Amino-2-oxy-substituerede tetrahydronaphthalenderivater, fremgangsmåder til fremstilling deraf og deres anvendelse som antiphlogistika
PT1893224T (pt) Utilização de uma membrana de célula vegetal para o tratamento da obesidade
DE602007011398D1 (de) Trialkylsilylbenzylaminocarboxyindole, indazole und indoline und ihre verwendung zur behandlung von cetp-vermittelten erkrankungen
DK1718340T3 (da) Nye effektorkonjugater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
NO20064715L (no) Deteksjon, isolering og anvendelse av renalase (monoamin aksidase C)
DE602005006105D1 (de) Membrankörper und entsprechendes herstellungsverfahren
NO20074780L (no) Heterocyklylamidsubstituerte imidazoler
DE502004005907D1 (de) Selbstemulgierende wässrige polyurethandispersionen
NO20092134L (no) Kombinasjonsprodukt for bruk i behandling av inflammatoriske lidelser
DK1727805T3 (da) 1-phenyl- og 1-pyridylpyrazolderivater og anvendelse deraf som pesticider
NO20082838L (no) 9-klor-15-deoksyprostaglandinderivater, fremgangsmate for fremstilling av disse, og anvendelse som medikamenter
NO20080034L (no) Benzotiazol-2-on derivater som lipase og fosfolipaseinhibitorer
NO20072794L (no) Kjemiske forbindelser
NO20065485L (no) Kjemiske forbindelser
NO20053598L (no) Substituerte 1-piperidin-3-yl-4-pyrrolidin-4-yl-piperazinderivater og deres anvendelse som nevrokininantagonister.
NO20091140L (no) Fremgangsmate for fremstilling av polyester nanokompositter

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application